Veracyte IncNASDAQ:VCYT
- LAST PRICE27.1400
- TODAY'S CHANGE (%)-0.7500 (-2.6891%)
- Bid / Lots27.1000/ 2
- Ask / Lots27.1500/ 1
- Open / Previous Close26.5700 / 27.8900
- Day Range
- 52 Week Range
- Volume134,223
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | VCYT |
|---|---|---|
| 09:32 ET | 14694 | 26.22 |
| 09:33 ET | 469 | 26.88 |
| 09:35 ET | 1300 | 26.75 |
| 09:37 ET | 100 | 26.82 |
| 09:42 ET | 500 | 26.74 |
| 09:44 ET | 2900 | 26.685 |
| 09:46 ET | 600 | 26.5 |
| 09:48 ET | 700 | 26.8 |
| 09:50 ET | 2413 | 26.72 |
| 09:51 ET | 1199 | 26.8 |
| 09:53 ET | 1730 | 26.735 |
| 09:55 ET | 1121 | 26.84 |
| 09:57 ET | 1150 | 26.75 |
| 10:00 ET | 545 | 26.755 |
| 10:02 ET | 2615 | 26.54 |
| 10:04 ET | 3390 | 26.59 |
| 10:06 ET | 5168 | 26.42 |
| 10:08 ET | 911 | 26.59 |
| 10:09 ET | 600 | 26.56 |
| 10:11 ET | 400 | 26.64 |
| 10:13 ET | 1854 | 26.825 |
| 10:15 ET | 350 | 26.75 |
| 10:18 ET | 700 | 26.915 |
| 10:20 ET | 3231 | 26.82 |
| 10:22 ET | 625 | 26.83 |
| 10:24 ET | 4016 | 27.02 |
| 10:26 ET | 300 | 27.045 |
| 10:27 ET | 3453 | 26.85 |
| 10:29 ET | 1552 | 26.8 |
| 10:31 ET | 900 | 26.9 |
| 10:33 ET | 839 | 26.96 |
| 10:36 ET | 1550 | 27.14 |
| 10:38 ET | 500 | 27.11 |
| 10:40 ET | 200 | 27.2 |
| 10:42 ET | 200 | 27.26 |
| 10:44 ET | 800 | 27.34 |
| 10:45 ET | 1400 | 27.48 |
| 10:47 ET | 700 | 27.41 |
| 10:49 ET | 600 | 27.43 |
| 10:51 ET | 400 | 27.39 |
| 10:54 ET | 100 | 27.32 |
| 10:56 ET | 400 | 27.38 |
| 10:58 ET | 1392 | 27.13 |
| 11:00 ET | 700 | 27.2 |
| 11:02 ET | 800 | 27.2 |
| 11:03 ET | 300 | 27.28 |
| 11:05 ET | 1003 | 27.27 |
| 11:07 ET | 300 | 27.21 |
| 11:09 ET | 100 | 27.26 |
| 11:12 ET | 100 | 27.27 |
| 11:14 ET | 1614 | 27.38 |
| 11:16 ET | 400 | 27.48 |
| 11:18 ET | 610 | 27.4 |
| 11:20 ET | 100 | 27.39 |
| 11:21 ET | 600 | 27.3 |
| 11:23 ET | 600 | 27.37 |
| 11:25 ET | 100 | 27.31 |
| 11:27 ET | 300 | 27.26 |
| 11:30 ET | 100 | 27.29 |
| 11:32 ET | 800 | 27.4 |
| 11:34 ET | 700 | 27.38 |
| 11:39 ET | 2156 | 27.285 |
| 11:41 ET | 500 | 27.32 |
| 11:43 ET | 700 | 27.3 |
| 11:45 ET | 100 | 27.27 |
| 11:48 ET | 679 | 27.25 |
| 11:50 ET | 1400 | 27.08 |
| 11:52 ET | 1284 | 27.14 |
Feb 1, 2023
Veracyte Announces Multiple Decipher Urologic Testing Abstracts to be Presented at the 2023 ASCO Genitourinary (GU) Cancers Symposium, from 4:05PM ET on Wednesday Feb 01, 2023 by Business Wire
4:05PM ET on Wednesday Feb 01, 2023 by Business WireVeracyte Announces New Data Suggesting Afirma Testing Can Help Personalize Care for Patients with Thyroid Nodules, from 8:32AM ET on Wednesday Feb 01, 2023 by Business Wire
8:32AM ET on Wednesday Feb 01, 2023 by Business Wire
Jan 23, 2023
Exagen Inc. Elects Tina S. Nova, Ph.D. as Executive Chair of the Board of Directors, from 9:00AM ET on Monday Jan 23, 2023 by GlobeNewswire
9:00AM ET on Monday Jan 23, 2023 by GlobeNewswire
Jan 18, 2023
Insider Sell: Veracyte, from 5:11PM ET on Wednesday Jan 18, 2023 by MT Newswires
5:11PM ET on Wednesday Jan 18, 2023 by MT NewswiresRaymond James Downgrades Veracyte to Market Perform From Outperform, from 7:56AM ET on Wednesday Jan 18, 2023 by MT Newswires
7:56AM ET on Wednesday Jan 18, 2023 by MT Newswires
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Veracyte Inc | 2.0B | -44.8x | --- |
BioCryst Pharmaceuticals Inc | 2.0B | -10.2x | --- |
Twist Bioscience Corp | 1.8B | -6.4x | --- |
Xencor Inc | 2.1B | 76.4x | +5.11% |
Syndax Pharmaceuticals Inc | 1.9B | -130.1x | --- |
FibroGen Inc | 2.3B | -6.5x | --- |
Company Information
Veracyte, Inc. is a genomic diagnostics company. The Company offers customized biomarker testing and analytical services. It offers a complete range of in vitro diagnostic (IVD) and companion diagnostic development services to biopharmaceutical companies and diagnostic companies. It offers tests across various diseases, which include Afirma Genomic Sequencing Classifier for thyroid cancer; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer; Prosigna Breast Cancer Assay for breast cancer; Genomic Sequencing Classifier and Percepta Nasal Swab Test for lung cancer; Envisia Genomic Classifier test for interstitial lung diseases; Decipher Bladder Genomic Classifier test for bladder cancer and Immunoscore Colon Cancer Test for colon cancer. It also offers Immunogram, a spatial molecular analysis and bioinformatics tool that integrates genomic, transcriptomic and proteomic data to help researchers understand the intricacies of the tumor immune microenvironment.
Contact Information
- Headquarters
- 6000 Shoreline Court, Suite 300SOUTH SAN FRANCISCO, CA, United States 94080
- Phone
- 650-243-6300
- Fax
- 650-243-6301
Executives
- Executive Chairman of the Board
- Bonnie Anderson
- Chief Executive Officer, Director
- Marc Stapley
- Chief Financial Officer
- Rebecca Chambers
- President - CLIA US
- Tina Nova
- Senior Vice President, General Counsel
- Annie Mcguire
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.0B |
|---|---|
Revenue (TTM) | $283.6M |
Shares Outstanding | 71.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.45 |
EPS | $-0.61 |
Book Value | $15.42 |
P/E Ratio | -44.8x |
Price/Sales (TTM) | 7.1 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -16.92% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
